# Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS)

> **NCT01440062** · PHASE2 · TERMINATED · sponsor: **Charite University, Berlin, Germany** · enrollment: 55 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Verum arm receiving Vitamin D oil
- **DRUG:** low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day

## Key facts

- **NCT ID:** NCT01440062
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2021-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01440062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01440062, "Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01440062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*